Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-23
DOI
10.1038/s41598-017-02442-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heterogeneity of Alcohol Use Disorder: Understanding Mechanisms to Advance Personalized Treatment
- (2015) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Subgroup Identification in Personalized Treatment of Alcohol Dependence
- (2015) Jue Hou et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
- (2015) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate
- (2015) Ralitza Gueorguieva et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Naltrexone vs Placebo for the Treatment of Alcohol Dependence
- (2015) David W. Oslin et al. JAMA Psychiatry
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects
- (2015) H W Nam et al. Translational Psychiatry
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
- (2014) V M Karpyak et al. Translational Psychiatry
- Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
- (2013) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Biomarkers for the Development of New Medications for Cocaine Dependence
- (2013) Kristopher J Bough et al. NEUROPSYCHOPHARMACOLOGY
- Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology and Neuro-Oncology
- (2013) Paul L Wood NEUROPSYCHOPHARMACOLOGY
- Acamprosate Produces Its Anti-Relapse Effects Via Calcium
- (2013) Rainer Spanagel et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
- (2013) Hongjie Zhu et al. PLoS One
- Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1
- (2012) David J. Hinton et al. NEUROPHARMACOLOGY
- Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia
- (2012) Jeffrey K. Yao et al. PLoS One
- Personalized Treatment of Alcohol Dependence
- (2012) Henry R. Kranzler et al. Current Psychiatry Reports
- Current progress in pharmacologic treatment strategies for alcohol dependence
- (2012) Peter Clapp Expert Review of Clinical Pharmacology
- 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
- (2011) Ruth Condray et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pharmacogenetic approaches to the treatment of alcohol addiction
- (2011) Markus Heilig et al. NATURE REVIEWS NEUROSCIENCE
- Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
- (2011) R Kaddurah-Daouk et al. Translational Psychiatry
- Effect of Acamprosate on Magnetic Resonance Spectroscopy Measures of Central Glutamate in Detoxified Alcohol-Dependent Individuals
- (2010) John C. Umhau et al. ARCHIVES OF GENERAL PSYCHIATRY
- Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1
- (2010) Moonnoh R. Lee et al. NEUROSCIENCE LETTERS
- Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate
- (2010) F Kiefer et al. PHARMACOGENOMICS JOURNAL
- Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes
- (2010) Ian R. Lanza et al. PLoS One
- Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators
- (2009) Wendy Ooteman et al. ADDICTION BIOLOGY
- OPRM1Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach
- (2008) Gabor Oroszi et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence
- (2008) Raymond F. Anton et al. ARCHIVES OF GENERAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now